JP2012532883A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532883A5
JP2012532883A5 JP2012519731A JP2012519731A JP2012532883A5 JP 2012532883 A5 JP2012532883 A5 JP 2012532883A5 JP 2012519731 A JP2012519731 A JP 2012519731A JP 2012519731 A JP2012519731 A JP 2012519731A JP 2012532883 A5 JP2012532883 A5 JP 2012532883A5
Authority
JP
Japan
Prior art keywords
compound according
compound
independently
unsubstituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012519731A
Other languages
English (en)
Japanese (ja)
Other versions
JP5925121B2 (ja
JP2012532883A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/041379 external-priority patent/WO2011005969A2/en
Publication of JP2012532883A publication Critical patent/JP2012532883A/ja
Publication of JP2012532883A5 publication Critical patent/JP2012532883A5/ja
Application granted granted Critical
Publication of JP5925121B2 publication Critical patent/JP5925121B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012519731A 2009-07-10 2010-07-08 副腎皮質ステロイド合成を阻害しないエトミデート類似体 Expired - Fee Related JP5925121B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22475109P 2009-07-10 2009-07-10
US61/224,751 2009-07-10
PCT/US2010/041379 WO2011005969A2 (en) 2009-07-10 2010-07-08 Etomidate analogues that do not inhibit adrenocortical steroid synthesis

Publications (3)

Publication Number Publication Date
JP2012532883A JP2012532883A (ja) 2012-12-20
JP2012532883A5 true JP2012532883A5 (pt-PT) 2013-08-22
JP5925121B2 JP5925121B2 (ja) 2016-05-25

Family

ID=43429834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519731A Expired - Fee Related JP5925121B2 (ja) 2009-07-10 2010-07-08 副腎皮質ステロイド合成を阻害しないエトミデート類似体

Country Status (10)

Country Link
US (2) US8765973B2 (pt-PT)
EP (1) EP2451779B1 (pt-PT)
JP (1) JP5925121B2 (pt-PT)
CN (1) CN102548964B (pt-PT)
AU (1) AU2010271345B2 (pt-PT)
BR (1) BR112012000606A2 (pt-PT)
CA (1) CA2767112C (pt-PT)
HK (1) HK1172026A1 (pt-PT)
RU (1) RU2559888C2 (pt-PT)
WO (1) WO2011005969A2 (pt-PT)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9156825B2 (en) * 2012-01-13 2015-10-13 The General Hospital Corporation Anesthetic compounds and related methods of use
SG10201705852PA (en) * 2012-11-14 2017-08-30 Teijin Pharma Ltd Pyridine derivative
JP2017531011A (ja) 2014-10-16 2017-10-19 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 麻酔のための新規の方法、化合物および組成物
CA3001128A1 (en) 2015-10-07 2017-04-13 Apellis Pharmaceuticals, Inc. Use of long-acting compstatin analog for treating a complement-mediated eye disorder
HUE058909T2 (hu) * 2015-10-10 2022-09-28 Jiangsu Nhwaluokang Pharmceutical Res And Development Co Ltd Etomidátszármazék és köztitermék, eljárás elõállítására és alkalmazása
CN107445898A (zh) * 2016-05-30 2017-12-08 四川海思科制药有限公司 N‑取代咪唑羧酸酯类化合物及其制备方法和在医药上的用途
CN107522662A (zh) * 2016-06-16 2017-12-29 四川海思科制药有限公司 N‑取代咪唑羧酸酯类化合物及其制备方法和在医药上的用途
CN107641105A (zh) * 2016-07-22 2018-01-30 四川海思科制药有限公司 N‑取代咪唑羧酸酯类化合物及其制备方法和在医药上的用途
CN107652239B (zh) * 2017-02-24 2020-08-04 四川大学华西医院 N-取代咪唑羧酸酯类化合物、制备方法及用途
KR20190139931A (ko) 2017-04-07 2019-12-18 아펠리스 파마슈티컬스 인코포레이티드 투여 요법 및 관련 조성물 및 방법
CN116120295A (zh) 2018-01-30 2023-05-16 成都麻沸散医药科技有限公司 一种n-取代咪唑甲酸酯类衍生物及其用途
CN110003188B (zh) * 2019-03-27 2022-08-26 成都麻沸散医药科技有限公司 取代吡咯甲酸酯类衍生物及其用途
CN110669017B (zh) * 2019-10-11 2023-08-04 成都麻沸散医药科技有限公司 多取代三唑甲酸酯类衍生物及其用途
CN112174890B (zh) * 2020-10-09 2022-05-27 成都麻沸散医药科技有限公司 酮取代杂环化合物及其麻醉作用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354173A (en) 1964-04-16 1967-11-21 Janssen Pharmaceutica Nv Imidazole carboxylates
US4038286A (en) 1975-03-10 1977-07-26 Janssen Pharmaceutica N.V. Racemates and optical isomers of 1-(1-phenylethyl)-1h-imidazole-5-carboylic acid derivatives
GR64915B (en) 1978-09-14 1980-06-09 Janssen Pharmaceutica Nv Improved etomidate-containing compositions
US4878940A (en) 1987-04-02 1989-11-07 Janssen Pharmaceutica N.V. Herbicidal 1,5-substituted 1H-imidazoles
US5041554A (en) * 1989-01-31 1991-08-20 Merrell Dow Pharmaceuticals Inc. Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
AU629290B2 (en) * 1989-01-31 1992-10-01 Merrell Dow Pharmaceuticals Inc. Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
US5019583A (en) 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5242939A (en) * 1990-09-28 1993-09-07 Warner-Lambert Company Anilide derivatives with angiotensin ii antagonist properties
JP3374922B2 (ja) 1991-05-09 2003-02-10 日産化学工業株式会社 複素環式第3級アミンの製造方法
JPH06345728A (ja) 1993-06-11 1994-12-20 Nissan Chem Ind Ltd N−置換アゾール誘導体の製造方法
US5466700A (en) 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5756528A (en) 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
RU2160265C1 (ru) * 2000-03-17 2000-12-10 Научно-исследовательский институт физической и органической химии Ростовского государственного университета Дигидрохлорид 1-(3-пирролидинопропил)-2-фенилимидазо [1,2-а]-бензимидазола, обладающий местноанестезирующим действием
EP1383445A4 (en) 2001-03-20 2005-04-13 Cydex Inc PREPARATION CONTAINING PROPOFOL AND SULFOALKYL ETHER CYCLODEXTRIN
ATE359783T1 (de) * 2001-12-27 2007-05-15 Ortho Mcneil Pharm Inc Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
WO2006023844A2 (en) 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
AU2009251659B2 (en) * 2008-03-31 2013-07-11 The General Hospital Corporation Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties

Similar Documents

Publication Publication Date Title
JP2012532883A5 (pt-PT)
JP2013032389A5 (pt-PT)
JP2010095546A5 (pt-PT)
JP2014500861A5 (pt-PT)
JP2015512946A5 (pt-PT)
JP2013518107A5 (pt-PT)
JP2013507423A5 (pt-PT)
JP2016534063A5 (pt-PT)
JP2013510885A5 (pt-PT)
JP2013510120A5 (pt-PT)
JP2010138190A5 (pt-PT)
JP2013545785A5 (pt-PT)
JP2009535462A5 (pt-PT)
JP2009530282A5 (pt-PT)
JP2011518833A5 (pt-PT)
JP2009519993A5 (pt-PT)
JP2014506907A5 (pt-PT)
JP2010511721A5 (pt-PT)
JP2012506896A5 (pt-PT)
JP2007302689A5 (pt-PT)
JP2010529994A5 (pt-PT)
JP2010527913A5 (pt-PT)
WO2009095872A3 (en) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
JP2014513051A5 (pt-PT)
RU2012104761A (ru) Аналоги этомидата, которые не ингибируют синтез адренокортикостероидов